XINOD

Welcome to the Brand page for “XINOD”, which is offered here for in the statement, column 1, line 5-17, pharmaceutical preparations and substances for the prevention and treatment of diseases and disorders of the respiratory system, central nervous system, peripheral nervous system, cardiovascular system, gastrointestinal system; pharmaceutical preparations and substances for use in pain control, arthritis, anaesthesia, oncology, infection, inflammation, urology, gynecology; pharmaceutical preparations and substances for the treatment and prevention of diabetes;; , should be deleted.;[pharmaceutical preparations and substances for the prevention and treatment of diseases and disorders of the respiratory system, central nervous system, peripheral nervous system, cardiovascular system, gastrointestinal system; pharmaceutical preparations and substances for use in pain control, arthritis, anaesthesia, oncology, infection, inflammation, urology, gynecology; pharmaceutical preparations and substances for the treatment and prevention of diabetes;; ] pharmaceutical preparations and substances for the prevention and treatment of diseases and disorders of the respiratory system, central nervous system, peripheral nervous system, cardiovascular system, gastrointestinal system; pharmaceutical preparations and substances for use in pain control, arthritis, anaesthesia, oncology, infection, inflammation, urology, gynecology; pharmaceutical preparations and substances for the treatment and prevention of diabetes;.

Its status is currently believed to be active. Its class is unavailable. “XINOD” is believed to be currently owned by “ASTRAZENECA UK LIMITED”.